[New] News / events

News / events

Corporate

22 October 2025

Symcel receives CEPI grant to accelerate vaccine sterility testing

Conference

27 - 29 Oct 2025

PDA Pharmaceutical Microbiology Conference 2025

Join us at the PDA Pharmaceutical Microbiology Conference 2025 in Washington DC

Conference

7 - 10 Oct 2025

European Society of Gene & Cell Therapy (ESGCT) 2025

Join us at ESGCT 2025 in Seville.

Corporate

16 SEPTEMBER 2025

Symcel enters into R&D collaboration with Johnson & Johnson to advance rapid sterility testing in cell & gene therapies

Conference

16 - 18 Sep 2025

Cell & Gene Therapy International

Join us at Cell & Gene Therapy International 2025 in Boston.

Corporate

10 JULY 2025

Symcel strengthens strategic position with new board member and senior leadership appointment

Corporate

28 May 2025

New investment boosts Symcel’s development and rollout of rapid sterility testing solutions for advanced therapies

Conference

13 - 15 May 2025

Biofilms 11 – Interdisciplinary Momentum: Accelerating Biofilm Research and Innovation Across Boundaries

Join us at Biofilm 11 2025 in Cardiff.

Conference

13 - 17 May 2025

American Society of Gene & Cell Therapy (ASGCT) 2025

Join us at American Society of Gene & Cell Therapy (ASGCT) 2025 in New Orleans.

Conference

7 - 10 May 2025

International Society for Cell & Gene Therapy (ISCT) 2025

Join us at International Society for Cell & Gene Therapy (ISCT) 2025 in New Orleans.

25th March 2025

LIVE WEBINAR: Investigating antimicrobial surfaces with isothermal calorimetry

Corporate

4th March 2025

Symcel's calScreener+™ to Power ALS’s New Sterility Testing Services for Cell and Gene Therapy Products

Conference

18 - 19 March 2025

Advanced Therapies 2025

Join us at Advance Therapies conference 2025 in London.

Conference

7th October 2024

PDA Pharmaceutical Microbiology Conference 2024

Join us at the PDA Pharmaceutical Microbiology Conference 2024 in Washington DC.

Conference

25th November 2024

ATMP Sweden

We'll be at ATMP Sweden 2024 in Malmö.

Conference

7th October 2024

Microbes 2024

We will be attending the French Microbiology Society Annual Meeting in Lille

Corporate

14th March 2024

Symcel raises 86 MSEK to develop the world’s fastest detection system of live bacteria

Corporate

8th February 2024

Next-Gen Microbiome and Probiotics

Corporate

12th October 2023

Symcel Appoints Pia van der Zee as Chief Commercial Officer to Spearhead Growth in Emerging Clinical Markets

Corporate

14th July 2023

Welcome to the team - Kasper Nørskov Kragh

Corporate

6th April 2023

Symcel Awarded Grant to Develop Fast Diagnostics for Joint Infections

Corporate

18th October 2022

NEW PUBLICATION: Bacteria control their metabolism when going into biofilm formation

Corporate

12th October 2022

Metastatic Esophageal Carcinoma Cells Exhibit Reduced Adhesion Strength and Enhanced Thermogenesis

Corporate

7th October 2022

Invited to speak at the United States Pharmacopeia on probiotics

Corporate

5th October 2022

Symcel establishes US operation with headquarters in Boston

Corporate

11th May 2022

NEW PUBLICATION: calScreener shows efficacy of antibiotic treatments against group A streptococci in a complex mammalian cell model

Corporate

11th May 2022

One step closer to a pill for weight loss without diet or exercise

Corporate

11th May 2022

NEW PUBLICATION: Giving antibiotics another chance in Cystic Fibrosis

Corporate

11th May 2022

News / events

Symcel receives CEPI grant to accelerate vaccine sterility testing

PDA Pharmaceutical Microbiology Conference 2025

European Society of Gene & Cell Therapy (ESGCT) 2025

Symcel enters into R&D collaboration with Johnson & Johnson to advance rapid sterility testing in cell & gene therapies

Cell & Gene Therapy International

Symcel strengthens strategic position with new board member and senior leadership appointment

New investment boosts Symcel’s development and rollout of rapid sterility testing solutions for advanced therapies

Biofilms 11 – Interdisciplinary Momentum: Accelerating Biofilm Research and Innovation Across Boundaries

American Society of Gene & Cell Therapy (ASGCT) 2025

International Society for Cell & Gene Therapy (ISCT) 2025

LIVE WEBINAR: Investigating antimicrobial surfaces with isothermal calorimetry

Symcel's calScreener+™ to Power ALS’s New Sterility Testing Services for Cell and Gene Therapy Products

Advanced Therapies 2025

PDA Pharmaceutical Microbiology Conference 2024

ATMP Sweden

Microbes 2024

Symcel raises 86 MSEK to develop the world’s fastest detection system of live bacteria

Next-Gen Microbiome and Probiotics

Symcel Appoints Pia van der Zee as Chief Commercial Officer to Spearhead Growth in Emerging Clinical Markets

Welcome to the team - Kasper Nørskov Kragh

Symcel Awarded Grant to Develop Fast Diagnostics for Joint Infections

NEW PUBLICATION: Bacteria control their metabolism when going into biofilm formation

Metastatic Esophageal Carcinoma Cells Exhibit Reduced Adhesion Strength and Enhanced Thermogenesis

Invited to speak at the United States Pharmacopeia on probiotics

Symcel establishes US operation with headquarters in Boston

NEW PUBLICATION: calScreener shows efficacy of antibiotic treatments against group A streptococci in a complex mammalian cell model

One step closer to a pill for weight loss without diet or exercise

NEW PUBLICATION: Giving antibiotics another chance in Cystic Fibrosis

Symcel raises 105 MSEK to develop rapid diagnostics to combat severe infections